Armata Pharmaceuticals Files 8-K with Officer/Director Changes
Ticker: ARMP · Form: 8-K · Filed: Apr 27, 2026 · CIK: 0000921114
| Field | Detail |
|---|---|
| Company | Armata Pharmaceuticals, Inc. (ARMP) |
| Form Type | 8-K |
| Filed Date | Apr 27, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: officer-changes, director-changes, regulation-fd, exhibits
TL;DR
Armata Pharma 8-K: Leadership changes filed, check exhibits for details.
AI Summary
Armata Pharmaceuticals, Inc. filed an 8-K on April 27, 2026, reporting changes in officers and directors, and providing Regulation FD disclosures. The filing also includes financial statements and exhibits, with specific XBRL data available for analysis.
Why It Matters
This filing indicates potential shifts in the company's leadership and governance, which could impact strategic direction and operational execution.
Risk Assessment
Risk Level: medium — Changes in officers and directors can signal internal shifts or strategic realignments that may carry inherent risks.
Key Numbers
- 29661 — 8-K Document Size (Size of the main 8-K filing document in bytes.)
- 12777 — Exhibit 99.1 Size (Size of Exhibit 99.1 in bytes, likely containing important disclosures.)
Key Players & Entities
- Armata Pharmaceuticals, Inc. (company) — Filer of the 8-K report
- 0000921114 (company) — CIK number for Armata Pharmaceuticals, Inc.
- 2026-04-27 (date) — Filing date of the 8-K
- 2026-04-24 (date) — Period of report for the 8-K
FAQ
What specific changes were made regarding officers or directors?
The filing indicates Item 5.02 covers 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers', but specific details would be found within the document exhibits.
What is the purpose of the Regulation FD Disclosure mentioned?
Item 7.01 pertains to Regulation FD Disclosure, which ensures that material information is broadly disseminated to the public, preventing selective disclosure.
Where can the financial statements and exhibits be found?
The filing lists 'Financial Statements and Exhibits' under Item 9.01, with specific documents like 'FORM 8-K' and 'EXHIBIT 99.1' provided in the document list.
What is the business address and contact information for Armata Pharmaceuticals?
The business address is 5005 MCCONNELL AVE, LOS ANGELES, CA 90066, and the phone number is 310-665-2928.
What is the SIC code and industry classification for Armata Pharmaceuticals?
The SIC code is 2836, classifying the company under 'Biological Products, (No Diagnostic Substances)' within the Life Sciences sector.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 27, 2026 regarding Armata Pharmaceuticals, Inc. (ARMP).